Outspoken biotech CEO Paul Hastings leaves Peninsula company (Video)
January 05, 2018 at 16:30 PM EST
Hastings, who had led OncoMed Pharmaceuticals since 2006, had become an industry force. But experimental cancer-fighting drugs from the Redwood City company over the past 18 months failed several clinical trials.
